The U.S. Vapor Technology Association (VTA) stated that only when there are viable alternatives to menthol-flavored cigarettes and flavored e-cigarette products on the market can the FDA's proposal regarding menthol-flavored cigarettes improve public health.
In April of this year, the FDA announced a plan to ban the sale of menthol-flavored cigarettes, which make up approximately one-third of the tobacco market in the United States. As of August 2nd, the officials are collecting public opinions on this plan.
In their official commentary on the proposed product standards, VTA urged the FDA to continue reforms for menthol and flavored electronic cigarette products, providing smokers with effective alternatives to traditional smoking.
In a statement, the VTA said that the "menthol cigarette rule" could potentially lead to a significant reduction in smoking - the leading cause of death and disease in the United States - but only if the agency heeds warnings from scientists that menthol smokers must have access to less harmful electronic cigarettes and other nicotine alternatives.
These restrictions may achieve a victory for public health and turn it into a benchmark. However, without the FDA taking further decisive action, this will fall far short of a triumph for public health.
Scientific experts of the FDA acknowledge that at least 50%, and possibly even more, of smokers will continue to smoke or use other combustible products unless provided with effective alternatives after the implementation of menthol cigarette regulations.
The VTA stated that in order to achieve its mission of harm reduction, the organization must utilize its PMTA process to ensure a reasonable and regulated market, while also providing suitable, less hazardous non-flammable alternatives.
Statement:
This article is compiled from information from third-party sources and is intended for industry professionals to share and learn from.
The views expressed in this article do not represent those of 2FIRSTS, and 2FIRSTS cannot confirm the truth or accuracy of the article's content. The translation of this article is solely for industry research and exchange.
Due to limitations in translation skills, the translated article may not accurately reflect the original text. Please refer to the original text for accuracy.
2FIRSTS maintains full consistency with the Chinese government's stance and positions on any domestic, Hong Kong, Macau, Taiwan, or foreign-related issues and statements.
The copyright of compiled information belongs to the original media and its author. If there is any infringement, please contact us for deletion.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
